| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

Department of Physiology, Faculty of Medicine, University of Manitoba, Winnipeg R3E 0W1 Canada, and Chiron Corporation (G.I.B.) Emeryville, California 94608
Address correspondence and requests for reprints to: Liam J. Murphy, M.D., Ph.D., Department of Physiology, University of Manitoba, 770 Bannatyne Avenue, Winnipeg, Manitoba R3E OW3, Canada.
Abstract
A complementary DNA (cDNA) encoding rat insulin-like growth factor 1 (IGF-I) has been isolated from a kidney cDNA library. By analogy with the sequence of human and mouse preproIGF-IA this cDNA encodes rat preproIGF-I from amino acid minus 3 to amino acid 105. The predicted protein sequence shows 96% and 99% homology with the human and mouse preproIGF-I, respectively. Under stringent conditions the rat IGF-I cDNA hybridizes with at least three mRNA, messenger RNA species which have apparent sizes of 7,1.8, and 0.7–1.1 kilobases. All three IGF-I transcripts are detectable in each of the normal rat tissues examined and the relative order of abundance in tissues from intact adult male rats is liver > lung > kidney > thymus > spleen > heart > skeletal muscle (quadriceps femoris) > testes > brain. The GH dependence of the IGF-I mRNAs was demonstrated by the administration of a single ip injection of human GH (hGH) to hypophysectomized (hypox) rats which resulted in an increase in all three transcripts in each of the tissues examined. The increase in IGF-1 mRNAs was most marked in skeletal and cardiac muscle (9.7- and 9.5- fold compared to hypox controls, respectively) and least marked in the brain. In the liver only a 4-fold increase in IGF-I expression was observed, possibly because of the relatively high level of IGF-I expression in the tissue in the hypox control rats. Each of the IGF-I messenger RNAs appeared to increase in parallel and the time course of IGF-I induction was similar in each tissue with maximal levels of IGF-I transcripts present 6 to 12 h after GH administration. A dose-dependent increase in IGF-I mRNAs was observed in most tissues of hypox rats treated for 10 days with hGH. Significant correlations between growth, as determined by body weight gain and IGF-I expression were observed in liver (r=0.97), kidney (r=0.90), quadriceps femoris (r=0.95), diaphragm (r=0.92), and thymus (r=1.0). The IGF-I mRNA levels in tissues from rats that had been treated with the highest dose of hGH (90 µg/ratday) were similar to those observed in normal intact rats. This study confirms the highly conserved nature of the IGF-I precursor and provides clear evidence for the GH dependence of IGF-I gene expression in multiple tissues of the rat. (Endocrinobgy 121: 684–691,1987)
Footnotes
* This work was supported by MRC Canada, National Cancer Institute of Canada, and USPHS Grant HD-07843-13.
Recipient of a C. J. Martin Travelling Fellowship from the NHMRC of Australia.
Received October 21, 1986.
This article has been cited by other articles:
![]() |
I. Ueki, S. L. Giesy, K. J. Harvatine, J. W. Kim, and Y. R. Boisclair The Acid-Labile Subunit Is Required for Full Effects of Exogenous Growth Hormone on Growth and Carbohydrate Metabolism Endocrinology, July 1, 2009; 150(7): 3145 - 3152. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Woodhouse, A. Mukherjee, S. M. Shalet, and S. Ezzat The Influence of Growth Hormone Status on Physical Impairments, Functional Limitations, and Health-Related Quality of Life in Adults Endocr. Rev., May 1, 2006; 27(3): 287 - 317. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Oldroyd, Y. Miyamoto, A. Moir, T. S. Johnson, A. M. El Nahas, and J. L. Haylor An IGF-I antagonist does not inhibit renal fibrosis in the rat following subtotal nephrectomy Am J Physiol Renal Physiol, March 1, 2006; 290(3): F695 - F702. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Daftary and A. C. Gore IGF-1 in the Brain as a Regulator of Reproductive Neuroendocrine Function Experimental Biology and Medicine, May 1, 2005; 230(5): 292 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Woelfle and P. Rotwein In vivo regulation of growth hormone-stimulated gene transcription by STAT5b Am J Physiol Endocrinol Metab, March 1, 2004; 286(3): E393 - E401. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Woelfle, J. Billiard, and P. Rotwein Acute Control of Insulin-like Growth Factor-I Gene Transcription by Growth Hormone through Stat5b J. Biol. Chem., June 13, 2003; 278(25): 22696 - 22702. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-T. Phan, I. J. Lim, B. H. Bay, R. Qi, M. T. Longaker, S.-T. Lee, and H. Huynh Role of IGF system of mitogens in the induction of fibroblast proliferation by keloid-derived keratinocytes in vitro Am J Physiol Cell Physiol, April 1, 2003; 284(4): C860 - C869. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. HOEFLICH, M. M. WEBER, T. FISCH, S. NEDBAL, C. FOTTNER, M. W. ELMLINGER, R. WANKE, and E. WOLF Insulin-like growth factor binding protein 2 (IGFBP-2) separates hypertrophic and hyperplastic effects of growth hormone (GH)/IGF-I excess on adrenocortical cells in vivo FASEB J, November 1, 2002; 16(13): 1721 - 1731. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zaczek, J. Hammond, L. Suen, S. Wandji, D. Service, A. Bartke, V. Chandrashekar, K. Coschigano, and J. Kopchick Impact of Growth Hormone Resistance on Female Reproductive Function: New Insights from Growth Hormone Receptor Knockout Mice Biol Reprod, October 1, 2002; 67(4): 1115 - 1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Chan, M. Pollak, and H. Huynh Inhibition of Insulin-like Growth Factor Signaling Pathways in Mammary Gland by Pure Antiestrogen ICI 182,780 Clin. Cancer Res., August 1, 2001; 7(8): 2545 - 2554. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hoeflich, S. Nedbal, W. F. Blum, M. Erhard, H. Lahm, G. Brem, H. J. Kolb, R. Wanke, and E. Wolf Growth Inhibition in Giant Growth Hormone Transgenic Mice by Overexpression of Insulin-Like Growth Factor-Binding Protein-2 Endocrinology, May 1, 2001; 142(5): 1889 - 1898. [Abstract] [Full Text] |
||||
![]() |
M. Brink, S. R. Price, J. Chrast, J. L. Bailey, A. Anwar, W. E. Mitch, and P. Delafontaine Angiotensin II Induces Skeletal Muscle Wasting through Enhanced Protein Degradation and Down-Regulates Autocrine Insulin-Like Growth Factor I Endocrinology, April 1, 2001; 142(4): 1489 - 1496. [Abstract] [Full Text] |
||||
![]() |
Measures of Submaximal Aerobic Performance Evaluate and Predict Functional Response to Growth Hormone (GH) Treatment in GH-Deficient Adults J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4570 - 4577. [Abstract] [Full Text] |
||||
![]() |
M. Brink, J. Chrast, S. R. Price, W. E. Mitch, and P. Delafontaine Angiotensin II Stimulates Gene Expression of Cardiac Insulin-Like Growth Factor I and Its Receptor Through Effects on Blood Pressure and Food Intake Hypertension, November 1, 1999; 34(5): 1053 - 1059. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Pampori and B. H. Shapiro Gender Differences in the Responsiveness of the Sex-Dependent Isoforms of Hepatic P450 to the Feminine Plasma Growth Hormone Profile Endocrinology, March 1, 1999; 140(3): 1245 - 1254. [Abstract] [Full Text] |
||||
![]() |
C. Costa, G. Solanes, J. Visa, and F. Bosch Transgenic rabbits overexpressing growth hormone develop acromegaly and diabetes mellitus FASEB J, November 1, 1998; 12(14): 1455 - 1460. [Abstract] [Full Text] |
||||
![]() |
T. M. Abdelbaky, G. B. Brock, and H. Huynh Improvement of Erectile Function in Diabetic Rats by Insulin: Possible Role of the Insulin-Like Growth Factor System Endocrinology, July 1, 1998; 139(7): 3143 - 3147. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Franchimont, V. Gangji, D. Durant, and E. Canalis Interleukin-6 with Its Soluble Receptor Enhances the Expression of Insulin-Like Growth Factor-I in Osteoblasts Endocrinology, December 1, 1997; 138(12): 5248 - 5255. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Rininsland, T. R. Johnson, C. L. Chernicky, E. Schulze, P. Burfeind, J. Ilan, and J. Ilan Suppression of insulin-like growth factor type I receptor by a triple-helix strategy inhibits IGF-I transcription and tumorigenic potential of rat C6 glioblastoma cells PNAS, May 27, 1997; 94(11): 5854 - 5859. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Bui, C. Kuo, P. Rotwein, and D. S. Straus Prostaglandin A2 Specifically Represses Insulin-Like Growth Factor-I Gene Expression in C6 Rat Glioma Cells Endocrinology, March 1, 1997; 138(3): 985 - 993. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Guron, P. Friberg, A. Wickman, C. Brantsing, B. Gabrielsson, and J. Isgaard Cardiac Insulin-like Growth Factor I and Growth Hormone Receptor Expression in Renal Hypertension Hypertension, March 1, 1996; 27(3): 636 - 642. [Abstract] [Full Text] |
||||
![]() |
M Griffin, R Bhandari, G Hamilton, Y. Chan, and J. Powell Alveolar type II cell-fibroblast interactions, synthesis and secretion of surfactant and type I collagen J. Cell Sci., January 6, 1993; 105(2): 423 - 432. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |